Alexion Pharmaceuticals Earnings: Here’s Why Shares are Up Now

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 4.34%.

Alexion Pharmaceuticals, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 0% to $0.6 in the quarter versus EPS of $0.41 in the year-earlier quarter.

Revenue: Rose 40.84% to $320.5 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Alexion Pharmaceuticals, Inc. reported adjusted EPS income of $0.6 per share. By that measure, the company beat the mean analyst estimate of $0.53. It beat the average revenue estimate of $316.49 million.

Quoting Management: “In 2012, we continued to expand the global presence of our PNH operations as we also commenced our activities to transform the lives of patients suffering with aHUS,” said Leonard Bell, M.D., Chief Executive Officer of Alexion. “Throughout 2013, we will focus on serving more patients with PNH and aHUS globally, and at the same time, we will advance our nine lead development programs in severe and ultra-rare disorders with Soliris and four additional highly innovative therapeutics.”

Key Stats (on next page)…

Revenue increased 8.96% from $294.14 million in the previous quarter. EPS decreased 0% from $0.60 in the previous quarter.

Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.6 to a profit $0.61. For the current year, the average estimate is a profit of $2.05, which is the same with that ninety days ago.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]